|
BP1 expression in breast cancer cell lines |
|||||
| Cell line |
ER |
PR |
Malignancy |
Tumorigenic* |
BP1 |
|
|
|||||
| Hs578T |
- |
- |
Ductal carcinoma |
No |
+/- |
| MCF7 |
+ |
+ |
Adenocarcinoma |
† |
++ |
| MCF7ADR‡ |
ADR-resistant |
Yes |
+++ |
||
| MDA-MB-231 |
- |
- |
Adenocarcinoma |
Yes |
++ |
| MDA-MB-435S |
- |
- |
Ductal carcinoma |
No |
+/- |
| MDA-MB-468 |
- |
- |
Adenocarcinoma |
Yes |
+++ |
| T-47D |
+ |
+ |
Ductal carcinoma |
† |
+++ |
| MCF10A |
+ |
+ |
Normal |
No |
+/- |
|
*Data from the American Type Culture Collection, except for T-47D [22,23]. †Not tumorigenic without the addition of estradiol. ‡Non-responsive to estradiol. ADR, adriamycin; ER, estrogen receptor; PR, progesterone receptor. | |||||
Fu et al. Breast Cancer Res 2003 5:R82 doi:10.1186/bcr602 |
|||||